1-7 of 7
Alexander Tischer
Close
Sort by
Journal Articles

Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor

Brief Report
Alexander Tischer, Laurie Moon-Tasson, Matthew Auton
Journal: Blood
Blood (2023) 141 (12): 1469–1473.
https://doi.org/10.1182/blood.2022018803
Published: 2023
Includes: Supplemental data
Journal Articles

Functional Interrogation of Variants of Undetermined Significance of the Isocitrate Dehydrogenase 1 and 2 Genes in Myeloid Neoplasms

Terra Lasho, PhD, Alexander Tischer, PhD, Guadalupe Belen Antelo, MD, Animesh Pardanani, MBBS, PhD, Christy Finke, BS, Giacomo Coltro, MD, Wilson I Gonsalves, MD, Ayalew Tefferi, MD, Abhishek A Mangaonkar, MBBS, Naseema Gangat, MBBS, Mrinal M Patnaik, MDMBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1697.
https://doi.org/10.1182/blood-2019-128067
Published: 2019
Journal Articles

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction

Reinhard Schneppenheim, Natalie Hellermann, Maria A. Brehm, Ulrike Klemm, Tobias Obser, Volker Huck, Stefan W. Schneider, Cécile V. Denis, Alexander Tischer, Matthew Auton, Winfried März, Emma-Ruoqi Xu, Matthias Wilmanns, Rainer B. Zotz
Journal: Blood
Blood (2019) 133 (4): 356–365.
https://doi.org/10.1182/blood-2018-04-843425
Published: 2019
Includes: Multimedia, Supplemental data
Journal Articles

The Von Willebrand Factor Tyr2561 Allele Is a Gain-of-Function Variant and a Potential Risk Factor for Early Myocardial Infarction

Reinhard Schneppenheim, MD PhD, Natalie Hellermann, MD, Maria Alexandra Brehm, PhD, Ulrike Klemm, PhD, Tobias Obser, Volker Huck, PhD, Stefan W Schneider, Cecile V. Denis, PhD, Alexander Tischer, PhD, Matthew Auton, BSc, PhD, Winfried Maerz, MD, Emma-Ruoqi Xu, PhD, Matthias Wilmanns, PhD, Rainer B. Zotz
Journal: Blood
Blood (2018) 132 (Supplement 1): 2459.
https://doi.org/10.1182/blood-2018-99-116085
Published: 2018
Journal Articles

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

Ayalew Tefferi, MD, Terra L Lasho, PhD, Alexander Tischer, PhD, Emnet A Wassie, MD, Christy Finke, BS, Alem A Belachew, Rhett Ketterling, MD, Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD
Journal: Blood
Blood (2014) 124 (21): 3166.
https://doi.org/10.1182/blood.V124.21.3166.3166
Published: 2014
Journal Articles

Misfolding Induced By the Mutations V1314D and F1369I Affects the Function and the Structure of the Von Willebrand A1-Domain

Alexander Tischer, PhD, Pranathi Madde, Laurie Moon Tasson, Matthew Auton, PhD
Journal: Blood
Blood (2014) 124 (21): 1521.
https://doi.org/10.1182/blood.V124.21.1521.1521
Published: 2014
Journal Articles

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Clinical Trials & Observations
Ayalew Tefferi, Terra L. Lasho, Alexander Tischer, Emnet A. Wassie, Christy M. Finke, Alem A. Belachew, Rhett P. Ketterling, Curtis A. Hanson, Animesh D. Pardanani
Journal: Blood
Blood (2014) 124 (15): 2465–2466.
https://doi.org/10.1182/blood-2014-07-588426
Published: 2014
Includes: Supplemental data